Nationwide Xanax recall raises concerns over the anxiety drug’s quality control
A safety recall has been issued for one specific batch of Xanax due to a quality issue. The FDA announced that the drugmaker Viatris is pulling a single lot of the extended-release (XR) 3-milligram tablets because they may not dissolve properly in the body. This could affect how the medication is absorbed and how well it works.
The risk to patients is considered very low and temporary. The recall is labeled as “Class II,” meaning any health problems from the defect would be minor and reversible. No adverse reactions have been reported from this batch, and officials say the action was taken “out of an abundance of caution.”
The affected bottles have a specific lot number and expiration date. Patients should check their medication’s bottle for the lot number 8177156 and the National Drug Code 58151-506-91. The tablets are 3 mg Xanax XR, and the expiration date is February 28, 2027.
Do not stop taking Xanax suddenly. Experts and officials strongly warn that abruptly quitting the drug can cause severe, even life-threatening withdrawal symptoms. Patients with the recalled batch should continue taking their medication as directed and contact their doctor immediately to get a new prescription.
Xanax remains a controversial and high-risk medication. The drug is known for its high potential for addiction and severe side effects, including withdrawal so difficult that it often requires hospitalization. This recall highlights the ongoing tension between the relief Xanax provides for anxiety and the serious risks it carries.
Read Full Article: https://www.naturalnews.com/2026-04-28-nationwide-xanax-recall-concerns-drug-quality-control.html
